Marchés français ouverture 24 min

Danaher Corporation (DHR)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
223,31+0,79 (+0,36 %)
À la clôture : 04:03PM EST
222,61 -0,70 (-0,31 %)
Échanges après Bourse : 07:56PM EST

Danaher Corporation

2200 Pennsylvania Avenue, North West
Suite 800 West
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein79 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Steven M. RalesCo-Founder & ChairmanS.O.S.O.1951
Mr. Rainer M. BlairPresident, CEO & Director5,93M5,83M1964
Mr. Mitchell P. RalesCo-Founder & DirectorS.O.S.O.1957
Mr. Matthew R. McGrewCFO & Executive VP2,85M4,12M1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer2,24MS.O.1963
Mr. Joakim WeidemanisExecutive Vice President3,13M6,28M1969
Mr. Christopher M. BoudaVP & Chief Accounting OfficerS.O.S.O.S.O.
Mr. John BedfordVice President of Investor RelationsS.O.S.O.S.O.
Mr. Brian W. EllisSenior VP, General Counsel & Chief Compliance Officer1,93MS.O.1967
Mr. Daniel A. Raskas J.D.Senior Vice President of Corporate DevelopmentS.O.S.O.1967
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Danaher Corporation en date du 28 novembre 2023 est 7. Les scores principaux sont Audit : 8; Société : 10; Droits des actionnaires : 3; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.